Aurinia Pharmaceuticals (AUPH) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $16.51, -1.31% vs the prior close of $16.73.
- Volume 736.08K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AUPH dips 1.3% to $16.51. Closed at $16.51, -1.31% vs the prior close of $16.73. Day range $16.35–$16.81, opened at $16.81.
AUPH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AUPH dips 1.3% to $16.51
- Closed at $16.51, -1.31% vs the prior close of $16.73. Day range $16.35–$16.81, opened at $16.81.
- Volume was 736.08K shares, 0.8x its 50-day average of 948.33K.
- Price is +1.8% vs its 50-day average ($16.23) and +6.0% vs its 200-day average ($15.57).
- 52-week range $11.30–$19.25; today's close sits at 66% of that range, 14.2% below the 52-week high.
Oct 15, 2026 — AUPH rises 0.7% to $16.73
- Closed at $16.73, +0.72% vs the prior close of $16.61. Day range $16.71–$17.30, opened at $16.84.
- Volume was 1.03M shares, 1.1x its 50-day average of 948.19K.
- Price is +3.2% vs its 50-day average ($16.22) and +7.5% vs its 200-day average ($15.57).
- 52-week range $11.21–$19.25; today's close sits at 69% of that range, 13.1% below the 52-week high.
Oct 14, 2026 — AUPH rises 1.5% to $16.61
- Closed at $16.61, +1.53% vs the prior close of $16.36. Day range $16.11–$16.82, opened at $16.24.
- Volume was 1.23M shares, 1.3x its 50-day average of 943.30K.
- Price is +2.6% vs its 50-day average ($16.19) and +6.7% vs its 200-day average ($15.56).
- 52-week range $10.90–$19.25; today's close sits at 68% of that range, 13.7% below the 52-week high.
Oct 13, 2026 — AUPH dips 1.1% to $16.36
- Closed at $16.36, -1.15% vs the prior close of $16.55. Day range $16.21–$16.58, opened at $16.46.
- Volume was 1.14M shares, 1.2x its 50-day average of 948.63K.
- Price is +1.3% vs its 50-day average ($16.15) and +5.1% vs its 200-day average ($15.56).
- 52-week range $10.90–$19.25; today's close sits at 65% of that range, 15.0% below the 52-week high.
Oct 12, 2026 — AUPH dips 0.6% to $16.55
- Closed at $16.55, -0.60% vs the prior close of $16.65. Day range $16.48–$16.70, opened at $16.61.
- Volume was 654.80K shares, 0.7x its 50-day average of 968.64K.
- Price is +2.7% vs its 50-day average ($16.12) and +6.4% vs its 200-day average ($15.56).
- 52-week range $10.90–$19.25; today's close sits at 68% of that range, 14.0% below the 52-week high.
Oct 9, 2026 — AUPH rises 2.7% to $16.65, 3 up days in a row
- Closed at $16.65, +2.65% vs the prior close of $16.22. Day range $16.12–$16.97, opened at $16.16.
- Volume was 849.20K shares, 0.9x its 50-day average of 973.21K.
- Price is +3.5% vs its 50-day average ($16.08) and +7.0% vs its 200-day average ($15.56).
- 52-week range $10.90–$19.25; today's close sits at 69% of that range, 13.5% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — AUPH rises 1.3% to $16.22
- Closed at $16.22, +1.31% vs the prior close of $16.01. Day range $15.80–$16.30, opened at $15.91.
- Volume was 831.00K shares, 0.9x its 50-day average of 974.27K.
- Price is +1.0% vs its 50-day average ($16.05) and +4.3% vs its 200-day average ($15.56).
- 52-week range $10.90–$19.25; today's close sits at 64% of that range, 15.7% below the 52-week high.
Oct 7, 2026 — AUPH rises 2.0% to $16.01
- Closed at $16.01, +2.04% vs the prior close of $15.69. Day range $15.50–$16.16, opened at $15.56.
- Volume was 682.50K shares, 0.7x its 50-day average of 994.87K.
- Price is -0.1% vs its 50-day average ($16.03) and +2.9% vs its 200-day average ($15.56).
- 52-week range $10.90–$19.25; today's close sits at 61% of that range, 16.8% below the 52-week high.
Oct 6, 2026 — AUPH ends flat (-0.2%) to $15.69, a 1-month low, 6 down days in a row
- Closed at $15.69, -0.19% vs the prior close of $15.72. Day range $15.47–$15.82, opened at $15.77.
- Volume was 698.70K shares, 0.7x its 50-day average of 1.00M.
- Price is -2.0% vs its 50-day average ($16.01) and +0.9% vs its 200-day average ($15.56).
- 52-week range $10.90–$19.25; today's close sits at 57% of that range, 18.5% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — AUPH dips 0.7% to $15.72, a 1-month low, 5 down days in a row
- Closed at $15.72, -0.69% vs the prior close of $15.83. Day range $15.60–$15.80, opened at $15.76.
- Volume was 802.20K shares, 0.8x its 50-day average of 1.00M.
- Price is -1.8% vs its 50-day average ($16.00) and +1.1% vs its 200-day average ($15.56).
- 52-week range $10.90–$19.25; today's close sits at 58% of that range, 18.3% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — AUPH dips 0.8% to $15.83, a 1-month low, 4 down days in a row
- Closed at $15.83, -0.75% vs the prior close of $15.95. Day range $15.74–$16.06, opened at $16.06.
- Volume was 813.40K shares, 0.8x its 50-day average of 999.09K.
- Price is -1.0% vs its 50-day average ($15.99) and +1.8% vs its 200-day average ($15.56).
- 52-week range $10.90–$19.25; today's close sits at 59% of that range, 17.8% below the 52-week high.
- That makes 4 straight losses.
AUPH latest news & SEC filings
Every SEC filing by or about AUPH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Robertson Stephen P. sold 11,939 shares at $15.95 (≈$190.43K) on Sep 10, 2026
- Robertson Stephen P. sold 11,939 shares at $15.95 (≈$190.43K) on Sep 10, 2026
- Robertson Stephen P. sold 11,939 shares at $15.95 (≈$190.43K) on Sep 10, 2026
- Robertson Stephen P. sold 11,939 shares at $15.95 (≈$190.43K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 26, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Robertson Stephen P. sold 20,975 shares at $16.97 (≈$355.95K) on Aug 21, 2026
- Robertson Stephen P. sold 20,975 shares at $16.97 (≈$355.95K) on Aug 21, 2026
- Robertson Stephen P. sold 20,975 shares at $16.97 (≈$355.95K) on Aug 21, 2026
- Robertson Stephen P. sold 20,975 shares at $16.97 (≈$355.95K) on Aug 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 21, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $83.22M (prior year $70.01M) (+18.9% vs Jun 30, 2025)
- Net income: $37.41M (prior year $21.51M) (+73.9% vs Jun 30, 2025)
- Diluted EPS: $0.28 (prior year $0.16) (+75.0% vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade AUPH
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.14% (largest 2.7%).
- Liquidity: about 828.11K shares (≈$13.67M) trade per day on average.
- 52-week position: $16.51 vs a range of $11.30–$19.25 (66% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 17 open-market buys, 8 sales; latest: Stephen P. Robertson sold 11,939 shares on Sep 10, 2026.
- Latest filings: 8-K Aug 19, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 133.05M shares outstanding (Aug 5, 2026), +1.1% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
AUPH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 16.81 | 16.81 | 16.35 | 16.51 | 736.08K |
| Oct 15, 2026 | 16.84 | 17.30 | 16.71 | 16.73 | 1.03M |
| Oct 14, 2026 | 16.24 | 16.82 | 16.11 | 16.61 | 1.23M |
| Oct 13, 2026 | 16.46 | 16.58 | 16.21 | 16.36 | 1.14M |
| Oct 12, 2026 | 16.61 | 16.70 | 16.48 | 16.55 | 654.80K |
| Oct 9, 2026 | 16.16 | 16.97 | 16.12 | 16.65 | 849.20K |
| Oct 8, 2026 | 15.91 | 16.30 | 15.80 | 16.22 | 831.00K |
| Oct 7, 2026 | 15.56 | 16.16 | 15.50 | 16.01 | 682.50K |
| Oct 6, 2026 | 15.77 | 15.82 | 15.47 | 15.69 | 698.70K |
| Oct 5, 2026 | 15.76 | 15.80 | 15.60 | 15.72 | 802.20K |
| Oct 2, 2026 | 16.06 | 16.06 | 15.74 | 15.83 | 813.40K |
| Oct 1, 2026 | 16.19 | 16.24 | 15.92 | 15.95 | 933.90K |
| Sep 30, 2026 | 16.43 | 16.44 | 16.19 | 16.19 | 913.80K |
| Sep 29, 2026 | 16.39 | 16.48 | 16.16 | 16.42 | 734.70K |
| Sep 28, 2026 | 16.41 | 16.62 | 16.24 | 16.52 | 626.20K |
| Sep 25, 2026 | 16.60 | 16.78 | 16.31 | 16.44 | 740.90K |
| Sep 24, 2026 | 16.35 | 16.66 | 16.28 | 16.59 | 809.20K |
| Sep 23, 2026 | 16.58 | 16.89 | 16.27 | 16.40 | 787.30K |
| Sep 22, 2026 | 16.72 | 16.81 | 16.55 | 16.67 | 885.00K |
| Sep 21, 2026 | 16.90 | 16.92 | 16.56 | 16.61 | 668.30K |
About Aurinia Pharmaceuticals
Aurinia Pharmaceuticals (AUPH) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in EDMONTON, Alberta, Canada. Fiscal year ends December 31. SEC CIK 1600620.
AUPH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jeffrey Allen Bailey | Director | Jun 8, 2026 |
| Kathleen Goetz | Director | Jun 8, 2026 |
| Peter Greenleaf | Chief Executive Officer | Mar 3, 2026 |
| Craig A Johnson | Director | Jun 8, 2026 |
| Tina Susan Nova | Director | Jun 8, 2026 |
| Kevin Tang | Chief Executive Officer | Jun 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ryan Cole | Chief Operating Officer | May 20, 2026 |
| Matthew Maxwell Donley | Chief Operating Officer | Mar 3, 2026 |
| Peter Greenleaf | Chief Executive Officer | Mar 3, 2026 |
| Michael S Hearne | Chief Financial Officer | May 20, 2026 |
| Greg Keenan | SVP, Chief Medical Officer | Mar 10, 2026 |
| Joseph M Miller | Chief Financial Officer | Mar 3, 2026 |
| Stephen P. Robertson | Chief Legal Officer | Sep 11, 2026 |
| Kevin Tang | Chief Executive Officer | Jun 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 10, 2026 | Stephen P. Robertson | Sale | 11,939 | $15.95 |
| Sep 10, 2026 | Stephen P. Robertson | Sale | 11,939 | $15.95 |
| Sep 10, 2026 | Stephen P. Robertson | Sale | 11,939 | $15.95 |
| Sep 10, 2026 | Stephen P. Robertson | Sale | 11,939 | $15.95 |
| Aug 21, 2026 | Stephen P. Robertson | Sale | 20,975 | $16.97 |
| Aug 21, 2026 | Stephen P. Robertson | Sale | 20,975 | $16.97 |
| Aug 21, 2026 | Stephen P. Robertson | Sale | 20,975 | $16.97 |
| Aug 21, 2026 | Stephen P. Robertson | Sale | 20,975 | $16.97 |
| Jun 2, 2026 | Kevin Tang | Buy | 206,005 | $15.28 |
| Jun 2, 2026 | Kevin Tang | Buy | 206,005 | $15.28 |
| Jun 2, 2026 | Capital Management Llc Tang | Buy | 206,005 | $15.28 |
| Jun 2, 2026 | Capital Management Llc Tang | Buy | 206,005 | $15.28 |
| Jun 2, 2026 | Kevin Tang | Buy | 206,005 | $15.28 |
| Jun 2, 2026 | Kevin Tang | Buy | 206,005 | $15.28 |
| Jun 2, 2026 | Capital Management Llc Tang | Buy | 206,005 | $15.28 |
AUPH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $283.06M | $287.20M | 2.07 | $135.66M |
| Dec 31, 2024 | $235.13M | $5.75M | 0.04 | $44.39M |
| Dec 31, 2023 | $175.51M | $-78.02M | -0.54 | $-33.46M |
| Dec 31, 2022 | $134.03M | $-108.18M | -0.76 | $-79.53M |
| Dec 31, 2021 | $45.60M | $-180.97M | -1.40 | $-157.69M |
Latest balance sheet: total assets $792.26M, total liabilities $177.40M, cash $179.73M (as of Jun 30, 2026).
AUPH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $16.13 |
| May 7, 2026 | 8-K Item 2.02 (results) | $15.14 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $13.97 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $14.27 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $9.24 |
| May 12, 2025 | 8-K Item 2.02 (results) | $8.12 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $7.55 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $8.34 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 15, 2024 | 8-K Item 2.02 (results) | — |
| Jan 5, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AUPH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.